Amyotrophic lateral sclerosis: update on clinical management

Area of Science:

• Neurology
• Neurodegenerative Diseases
• Clinical Medicine

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting motor neurons, leading to paralysis and respiratory failure.
• Currently, no cure exists for ALS, highlighting the need for effective clinical management strategies.
• Multidisciplinary care, symptom management, and pharmacological interventions are crucial for improving quality of life and survival in ALS patients.

Purpose of the Study:

• To provide recent updates on the clinical management of amyotrophic lateral sclerosis (ALS).
• To highlight the impact of new treatments, genetic discoveries, and clinical staging systems on ALS care.
• To discuss the role of the COVID-19 pandemic in advancing telemedicine and remote monitoring for ALS patients.

Main Methods:

• This review synthesizes recent findings and developments in ALS clinical management.
• It examines the influence of increased genetic knowledge on understanding ALS pathophysiology.
• The review assesses the utility of clinical staging systems and measures for disease monitoring.

Main Results:

• Growing knowledge of ALS genetics offers insights into disease mechanisms.
• Clinical staging systems and measures provide valuable tools for monitoring disease progression.
• The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring, enhancing care accessibility and reducing patient/caregiver burden.

Conclusions:

• Despite the absence of a cure, advancements in understanding and management are improving outcomes for individuals with ALS.
• Integrating new treatments, genetic insights, and technological solutions like telemedicine can optimize patient care.
• Proactive multidisciplinary care remains essential for managing ALS symptoms and enhancing survival.